Literature DB >> 1295092

Diseases associated with calcium pyrophosphate deposition disease.

A C Jones1, A J Chuck, E A Arie, D J Green, M Doherty.   

Abstract

Although many metabolic and endocrine diseases have been reported to predispose to calcium pyrophosphate dihydrate crystal deposition, the validity of many of these associations remains unclear. A critical review of the literature relating to these associations, with illustrative cases and data derived from the authors' own experience, is presented. It is concluded that there is good evidence to associate hypophosphatasia, hypomagnesemia, and hyperparathyroidism with chondrocalcinosis and acute attacks of "pseudogout." Meta-analysis also suggests a small but significant association between hypothyroidism and chondrocalcinosis. Hemochromatosis stands alone in clearly associating not only with chondrocalcinosis but also with structural change and chronic arthropathy. The biochemical mechanisms that may produce these various associations are discussed. Recommendations are made concerning appropriate screening for metabolic and endocrine disease in patients with chondrocalcinosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295092     DOI: 10.1016/0049-0172(92)90019-a

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  29 in total

1.  Pseudogout, hypomagnesemia, and liver transplantation.

Authors:  Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

2.  Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy.

Authors:  W Zhang; R Neame; S Doherty; M Doherty
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  Linear joint calcifications while treating osteoporosis: in flagrante delicto?

Authors:  Levent Ozçakar; Ayşen Akinci
Journal:  Rheumatol Int       Date:  2004-04-01       Impact factor: 2.631

Review 4.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 5.  Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.

Authors:  Akanksha Joshi; Chokkalingam Siva
Journal:  Eur J Rheumatol       Date:  2017-08-29

6.  Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.

Authors:  Crystal Kleiber Balderrama; Ann K Rosenthal; Daniel Lans; Jasvinder A Singh; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

Review 7.  Rheumatoid arthritis in the elderly. Prevalence and optimal management.

Authors:  D van Schaardenburg
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

8.  Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes.

Authors:  M Lotz; F Rosen; G McCabe; J Quach; F Blanco; J Dudler; J Solan; J Goding; J E Seegmiller; R Terkeltaub
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 9.  [Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

Review 10.  How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?

Authors:  C Beck; H Morbach; P Richl; M Stenzel; H J Girschick
Journal:  Rheumatol Int       Date:  2008-09-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.